JP3209679B2 - Disulfide compound and method for producing the same - Google Patents

Disulfide compound and method for producing the same

Info

Publication number
JP3209679B2
JP3209679B2 JP10860296A JP10860296A JP3209679B2 JP 3209679 B2 JP3209679 B2 JP 3209679B2 JP 10860296 A JP10860296 A JP 10860296A JP 10860296 A JP10860296 A JP 10860296A JP 3209679 B2 JP3209679 B2 JP 3209679B2
Authority
JP
Japan
Prior art keywords
formula
compound
reaction
represented
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP10860296A
Other languages
Japanese (ja)
Other versions
JPH09278776A (en
Inventor
聖 玉井
壽 清水
一記 山村
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Japan Inc
Original Assignee
Wyeth GK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth GK filed Critical Wyeth GK
Priority to JP10860296A priority Critical patent/JP3209679B2/en
Publication of JPH09278776A publication Critical patent/JPH09278776A/en
Application granted granted Critical
Publication of JP3209679B2 publication Critical patent/JP3209679B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明はジスルフィド化合物
に係り、詳細には、カルバペネム化合物の合成中間体で
あるチオール化合物へ誘導するために有用な化合物であ
る、ジスルフィド化合物およびその酸付加塩、ならびに
その製造法に関する。
The present invention relates to a disulfide compound, and more particularly, to a disulfide compound, an acid addition salt thereof, and a compound useful for deriving a thiol compound which is a synthetic intermediate of a carbapenem compound. Related to manufacturing method.

【0002】[0002]

【従来の技術】これまでに、いわゆるカルバペネム骨格
を有する多くの化合物が見いだされてきており、そのな
かから優れた抗菌活性を有する化合物もいくつか提案さ
れている。本発明者らも、強力な抗菌活性を示し、しか
もβ−ラクタマーゼ阻害作用ならびに腎デヒドロペプチ
ダーゼ−I(DHP−I)に対する優れた耐性を有する
カルバペネム化合物の検索を検討してきたが、その中で
カルバペネム骨格の2位の置換基として特異的な1−
(1,3−チアゾリン−2−イル)アゼチジン−3−イ
ルチオ基を導入した次式(A):
2. Description of the Related Art Many compounds having a so-called carbapenem skeleton have been found so far, and some compounds having excellent antibacterial activity have been proposed. The present inventors have also studied the search for carbapenem compounds which exhibit strong antibacterial activity and also have a β-lactamase inhibitory action and excellent resistance to renal dehydropeptidase-I (DHP-I). 1-specific as a substituent at the 2-position of the skeleton
The following formula (A) in which a (1,3-thiazolin-2-yl) azetidin-3-ylthio group is introduced:

【0003】[0003]

【化9】 Embedded image

【0004】で示される(1R,5S,6S)−2−
[1−(1,3−チアゾリン−2−イル)アゼチジン−
3−イル]チオ−6−[(R)−1−ヒドロキシエチ
ル]−1−メチル−カルバペン−2−エム−3−カルボ
ン酸を新規に見いだし、提案している(特開平8−53
453号公報)。上記式(A)で示されるカルバペネム
化合物は、それ自体で強力な抗菌活性を示すばかりでな
く、3位のカルボキシ基を特定のエステル残基でエステ
ル化した化合物は、経口投与されることにより消化管か
らの吸収性も良く、しかも生体内で速やかにエステル加
水分解されることにより活性本体に移行することより、
従来には見られない経口投与可能なカルバペネム抗生剤
としてその臨床的応用が広く、開発が望まれている化合
物である。ところで、これまでの上記式(A)で示され
るカルバペネム化合物の製造は、例えば下記反応式
(a)で示す方法で行われていた。
(1R, 5S, 6S) -2-
[1- (1,3-thiazolin-2-yl) azetidine-
3-yl] thio-6-[(R) -1-hydroxyethyl] -1-methyl-carbapen-2-em-3-carboxylic acid has been newly found and proposed (JP-A-8-53).
453). The carbapenem compound represented by the above formula (A) not only exhibits a strong antibacterial activity by itself, but also a compound obtained by esterifying the carboxy group at the 3-position with a specific ester residue is digested by oral administration. It has good absorbability from the tube, and moreover, it is rapidly hydrolyzed in vivo in the ester to transfer to the active form,
It is a compound that has been widely expected as a carbapenem antibiotic that can be orally administered and that has never been seen before, and that has been desired to be developed. By the way, the production of the carbapenem compound represented by the above formula (A) has been performed by, for example, a method represented by the following reaction formula (a).

【0005】[0005]

【化10】 Embedded image

【0006】この従来の化合物(A)の製造において
は、化合物(B)と反応させる式(II)で示される化
合物は、具体的には下記反応式(b)に示すように、式
(III)の3−メルカプトアゼチジンに式(IV)の
2−置換−1,3−チアゾリン誘導体を反応させる方法
により製造され、かくして製造された式(II)の化合
物が、式(B)で示される化合物との反応に用いられて
いた。
In the production of the conventional compound (A), the compound of the formula (II) reacted with the compound (B) is specifically converted to the compound of the formula (III) as shown in the following reaction formula (b). The compound of formula (II) produced by reacting the 2-substituted-1,3-thiazoline derivative of formula (IV) with the 3-mercaptoazetidine of formula (IV) is represented by the formula (B) Used for reaction with compounds.

【0007】[0007]

【化11】 Embedded image

【0008】(式中、Lは脱離基を表す) しかしながら、上記反応式(b)に従い製造される式
(II)で示される化合物は、かかる製造法では純度的
に純粋な形で得るのが困難であり、必然的に夾雑物が混
在しているものしか得られず、その分離も困難なもので
あった。したがって、この方法で製造された式(II)
で示される化合物を用い、式(B)で示される化合物と
反応させて式(C)で示される化合物を得る工程での反
応収率には限界があり、工業的な製造法としてはいまだ
問題があり、優れた抗菌活性を有し、臨床的にその開発
が強く望まれている式(A)のカルバペネム化合物を効
率よく得るためには、より純度の高い式(II)で示さ
れる化合物の開発ならびにその工業的応用が可能となる
製造法の確立が望まれていた。
(Wherein L represents a leaving group) However, the compound represented by the formula (II) produced according to the above reaction formula (b) can be obtained in a pure form by such a production method. However, it was inevitable that only a mixture containing contaminants was obtained, and its separation was also difficult. Therefore, the formula (II) produced by this method
The reaction yield in the step of using the compound represented by the formula (B) to react with the compound represented by the formula (B) to obtain the compound represented by the formula (C) is limited, and is still a problem as an industrial production method. In order to efficiently obtain a carbapenem compound of the formula (A), which has excellent antibacterial activity and is strongly desired for clinical development, it is necessary to use a compound of the formula (II) having a higher purity. It has been desired to establish a production method that enables development and industrial application thereof.

【0009】本発明者らは上記実情にかんがみ、鋭意検
討を加えた結果、次式(I):
In view of the above circumstances, the present inventors have made intensive studies and found that the following formula (I):

【0010】[0010]

【化12】 Embedded image

【0011】で示されるジスルフィド化合物を還元して
式(II)で示される化合物へ誘導する場合には、目的
とする式(II)の化合物の収率がほぼ定量的なもので
あるとともに、不純物の混在もなく、かくして製造され
た式(II)の化合物を反応式(a)に従い化合物
(B)と反応させ、式(C)で示される化合物へ誘導す
る場合には、化合物(C)の反応収率が飛躍的に上昇す
ることが判明し、工業的な製造方法として極めて有用な
ものであることを新規に見いだした。したがって本発明
は、カルバペネム化合物の合成中間体であるチオール化
合物へ誘導するのに有用な上記式(I)で示される化合
物およびその製造法を提供するものである。
When the disulfide compound of the formula (II) is reduced to the compound of the formula (II), the yield of the desired compound of the formula (II) is almost quantitative, and When the compound of the formula (II) thus produced is reacted with the compound (B) according to the reaction formula (a) to derive the compound represented by the formula (C), the compound (C) The reaction yield was found to be dramatically increased, and was newly found to be extremely useful as an industrial production method. Accordingly, the present invention provides a compound represented by the above formula (I), which is useful for deriving a thiol compound which is a synthetic intermediate of a carbapenem compound, and a method for producing the same.

【0012】[0012]

【課題を解決するための手段】すなわち本発明は、次式
(I):
That is, the present invention provides the following formula (I):

【0013】[0013]

【化13】 Embedded image

【0014】で示されるジスルフィド化合物およびその
酸付加塩を提供する。また本発明は、上記式(I)で示
されるジスルフィド化合物の製造法を提供するものであ
り、具体的には、次式(II):
And a disulfide compound and an acid addition salt thereof. The present invention also provides a method for producing the disulfide compound represented by the above formula (I). Specifically, the present invention provides the following formula (II):

【0015】[0015]

【化14】 Embedded image

【0016】で示される3−メルカプト−1−(1,3
−チアゾリン−2−イル)アゼチジンまたはその酸付加
塩を酸化反応に付すことにより式(I)の化合物を得る
製造法を提供する。さらに本発明は、式(I)のジスル
フィド化合物の別の製造法を提供するものであり、具体
的には次式(III):
3-mercapto-1- (1,3
A process for obtaining a compound of formula (I) by subjecting -thiazolin-2-yl) azetidine or an acid addition salt thereof to an oxidation reaction is provided. Further, the present invention provides another method for producing the disulfide compound of the formula (I), specifically, the following formula (III):

【0017】[0017]

【化15】 Embedded image

【0018】で示される3−メルカプトアゼチジンに、
次式(IV):
The 3-mercaptoazetidine represented by
The following formula (IV):

【0019】[0019]

【化16】 Embedded image

【0020】(式中、Lは脱離基を表す)で示される2
−置換−1,3−チアゾリン誘導体を反応させ、次式
(II):
(Wherein L represents a leaving group)
Reacting a substituted-1,3-thiazoline derivative with the following formula (II):

【0021】[0021]

【化17】 Embedded image

【0022】で示される3−メルカプト−1−(1,3
−チアゾリン−2−イル)アゼチジンを得、次いで得ら
れる式(II)の化合物を反応液から単離することなく
そのまま酸化反応に付すことにより、式(I)の化合物
を得る製造法を提供する。また本発明は、式(I)のジ
スルフィド化合物の更に別の製造法を提供するものであ
り、具体的には、次式(V):
3-mercapto-1- (1,3
(Thiazolin-2-yl) azetidine is obtained, and the resulting compound of the formula (II) is directly subjected to an oxidation reaction without isolation from the reaction solution to provide a process for obtaining the compound of the formula (I). . The present invention also provides still another method for producing the disulfide compound of the formula (I). Specifically, the present invention provides the following formula (V):

【0023】[0023]

【化18】 Embedded image

【0024】で示される化合物に、次式(IV):The compound represented by the following formula (IV):

【0025】[0025]

【化19】 Embedded image

【0026】(式中、Lは脱離基を表す)で示される2
−置換−1,3−チアゾリン誘導体を反応させることに
よる式(I)の化合物の製造法を提供する。更に本発明
の別の態様は、式(I)のジスルフィド化合物へ誘導す
る原料となる化合物の提供にも係り、具体的には次式
(VI):
(Wherein L represents a leaving group)
-To provide a process for the preparation of a compound of formula (I) by reacting a substituted-1,3-thiazoline derivative. Still another embodiment of the present invention relates to the provision of a compound as a raw material for deriving the disulfide compound of the formula (I), and specifically, the following formula (VI):

【0027】[0027]

【化20】 Embedded image

【0028】(式中、R1 は水素原子またはアミノ保護
基を表す)で示される化合物を提供する。以上の本発明
が提供する式(I)で示されるジスルフィド化合物およ
びその酸付加塩は、還元反応に付すことにより純度よく
式(II)で示されるチオール化合物へ定量的に誘導さ
れ、かくして誘導された式(II)のチオール化合物を
用い、優れた抗菌活性を有し、エステル化により経口投
与も可能となる前記式(A)で示されるカルバペネム化
合物を、工業的規模でしかも収率よく製造することがで
きる。
(Wherein R 1 represents a hydrogen atom or an amino-protecting group). The disulfide compound represented by the formula (I) and the acid addition salt thereof provided by the present invention can be quantitatively derived to a thiol compound represented by the formula (II) with high purity by subjecting the compound to a reduction reaction. Using the thiol compound of formula (II), a carbapenem compound represented by the formula (A) having excellent antibacterial activity and capable of oral administration by esterification is produced on an industrial scale with high yield. be able to.

【0029】[0029]

【発明の実施の形態】以下に本発明を詳細に説明する
が、本発明の式(I)で示されるジスルフィド化合物
は、以下の反応式(c)で示す方法で製造することがで
きる。
BEST MODE FOR CARRYING OUT THE INVENTION The present invention will be described in detail below. The disulfide compound represented by the formula (I) of the present invention can be produced by the method represented by the following reaction formula (c).

【0030】[0030]

【化21】 Embedded image

【0031】(式中、Lは脱離基を表し、R2 はアミノ
保護基を表す。また[ ]内の数字は説明の便宜のため
の反応工程を示す) 本明細書中において,Lによって表される「脱離基」と
しては、例えば、アジド基;塩素、臭素、フッ素等のハ
ロゲン原子;アセトキシ、プロピオニルオキシ基等の低
級アルカノイルオキシ基;ベンゼンスルホニルオキシ、
トシルオキシ、メタンスルホニルオキシ基等のスルホニ
ルオキシ基;メトキシ、エトキシ等の低級アルコキシ
基;メチルチオ、エチルチオ等の低級アルキルチオ基を
挙げることができる。
Wherein L represents a leaving group, R 2 represents an amino-protecting group, and the numbers in brackets denote reaction steps for convenience of explanation. Examples of the "leaving group" represented include, for example, an azide group; a halogen atom such as chlorine, bromine and fluorine; a lower alkanoyloxy group such as acetoxy and propionyloxy group; benzenesulfonyloxy;
Sulfonyloxy groups such as tosyloxy and methanesulfonyloxy groups; lower alkoxy groups such as methoxy and ethoxy; lower alkylthio groups such as methylthio and ethylthio.

【0032】またR1 またはR2 によって表される「ア
ミノ保護基」としては、ペプチド化学の分野においてア
ミノ基の保護基としてそれ自体公知の任意の保護基であ
る。具体的には、例えば、(1) フタロイル;ベンゾイ
ル、またはクロロベンゾイル、p−ニトロベンゾイル、
p−tert−ブチルベンゾイル、トリオイルなどのハロゲ
ン、ニトロもしくは低級アルキルで置換されたベンゾイ
ル;ナフトイル;フェニルアセチル;フェノキシアセチ
ル;ベンゼンスルホニル、p−tert−ブチルベンゼンス
ルホニル、トルエンスルホニルなどの低級アルキルベン
ゼンスルホニル等;(2) 脂肪族またはハロゲン化脂肪族
カルボン酸アシル基:例えば、カンファスルホニル、メ
タンスルホニル、ホルミル、アセチル、バレリル、カプ
リル、n−デカノイル、アクリロイル、ピバロイル、ハ
ロゲノアセチル(例、モノクロロアセチル、モノブロモ
アセチル、ジクロロアセチル、トリクロロアセチル)
等;(3) エステル化されたカルボキシ基:例えば、エト
キシカルボニル、tert−ブチルオキシカルボニル、アリ
ルオキシカルボニル、イソボルニルオキシカルボニル、
フェニルオキシカルボニル、トリクロロエトキシカルボ
ニル、ベンジルオキシカルボニル、p−ニトロベンジル
オキシカルボニル等;(4) カルバモイルまたはチオカル
バモイル基:例えば、メチルカルバモイル、フェニルカ
ルバモイル、ナフチルカルバモイル等もしくはこれらに
対応するチオカルバモイル基、等が挙げられる。
The "amino protecting group" represented by R 1 or R 2 is any protecting group known per se as a protecting group for an amino group in the field of peptide chemistry. Specifically, for example, (1) phthaloyl; benzoyl, or chlorobenzoyl, p-nitrobenzoyl,
benzoyl substituted with halogen, nitro or lower alkyl such as p-tert-butylbenzoyl and trioil; naphthoyl; phenylacetyl; phenoxyacetyl; lower alkylbenzenesulfonyl such as benzenesulfonyl, p-tert-butylbenzenesulfonyl and toluenesulfonyl; (2) aliphatic or halogenated aliphatic carboxylic acid acyl group: for example, camphorsulfonyl, methanesulfonyl, formyl, acetyl, valeryl, capryl, n-decanoyl, acryloyl, pivaloyl, halogenoacetyl (eg, monochloroacetyl, monobromoacetyl) , Dichloroacetyl, trichloroacetyl)
And (3) an esterified carboxy group: for example, ethoxycarbonyl, tert-butyloxycarbonyl, allyloxycarbonyl, isobornyloxycarbonyl,
Phenyloxycarbonyl, trichloroethoxycarbonyl, benzyloxycarbonyl, p-nitrobenzyloxycarbonyl and the like; (4) carbamoyl or thiocarbamoyl group: for example, methylcarbamoyl, phenylcarbamoyl, naphthylcarbamoyl and the like or a corresponding thiocarbamoyl group; Is mentioned.

【0033】本発明が提供する式(I)および(II)
示される化合物等はいずれも任意の酸付加塩として単離
することができる。そのような付加し得る酸のうち有機
酸としては、例えば酢酸、プロピオン酸、酪酸、トリフ
ルオロ酢酸、トリクロロ酢酸等の低級脂肪酸;安息香
酸、p−ニトロ安息香酸等の置換もしくは未置換の安息
香酸;メタンスルホン酸、トリフルオロメタンスルホン
酸等の(ハロ)低級アルキルスルホン酸;ベンゼンスル
ホン酸、p−ニトロベンゼンスルホン酸、p−ブロモベ
ンゼンスルホン酸、トルエンスルホン酸、2,4,6−
トリイソプロピルベンゼンスルホン酸等の置換もしくは
未置換のアリールスルホン酸;ジフェニルリン酸等の有
機リン酸を例示することができる。また無機酸として
は、例えば、塩酸、硫酸、臭化水素酸、ヨウ化水素酸、
ホウフッ化水素酸、過塩素酸、硝酸等を例示することが
できる。
Formulas (I) and (II) provided by the present invention
Any of the compounds and the like shown can be isolated as an arbitrary acid addition salt. Organic acids among such acids that can be added include, for example, lower fatty acids such as acetic acid, propionic acid, butyric acid, trifluoroacetic acid, and trichloroacetic acid; and substituted or unsubstituted benzoic acids such as benzoic acid and p-nitrobenzoic acid. (Halo) lower alkylsulfonic acids such as methanesulfonic acid and trifluoromethanesulfonic acid; benzenesulfonic acid, p-nitrobenzenesulfonic acid, p-bromobenzenesulfonic acid, toluenesulfonic acid, 2,4,6-
Substituted or unsubstituted arylsulfonic acids such as triisopropylbenzenesulfonic acid; and organic phosphoric acids such as diphenylphosphoric acid. As the inorganic acid, for example, hydrochloric acid, sulfuric acid, hydrobromic acid, hydroiodic acid,
Examples thereof include borofluoric acid, perchloric acid, and nitric acid.

【0034】以下に本発明を、上記反応式(c)におけ
る各工程を説明することにより行なう。工程[1] :本工程は、式(II)で示される3−メル
カプト−1−(1,3−チアゾリン−2−イル)アゼチ
ジンを酸化反応に付し、本発明の目的化合物である式
(I)で示されるジスルフィド化合物へ誘導する工程で
ある。反応は、式(II)の化合物を適当な溶媒中、ク
ロム酸、四酢酸鉛、有機過酸、H22 、I2 、ジメチ
ルスルホキシド等の酸化剤を用いる方法、あるいは三塩
化鉄等の触媒の存在下に、反応液中に空気を通じる空気
酸化を行なう方法により達成される。使用する溶媒とし
ては、かかる酸化反応に影響を与えない溶媒、すなわち
反応に不活性な溶媒であれば良く、例えば、メタノー
ル、エタノール、プロパノール、n−ブタノールなどの
アルコール系溶媒;ジエチルエーテル、テトラヒドロフ
ランなどのエーテル系溶媒;n−ヘプタン、n−ヘキサ
ン、シクロヘキサン、ペンタン、シクロペンタン等の炭
化水素系溶媒;酢酸メチルエステル、酢酸エチルエステ
ル等のエステル系溶媒;ジクロルメタン、クロロホル
ム、四塩化炭素等のハロゲン系溶媒;アセトニトリル、
ジメチルホルムアミド、ジメチルアセトアミド、ジメチ
ルスルホキシド等の溶媒が使用でき、なかでもアルコー
ル系溶媒が好ましく、特にメタノール、エタノールがと
りわけ好ましい。この場合、式(II)の化合物として
は、その酸付加塩を用いることも可能であり、かかる場
合にあっては、例えば、炭酸水素カリウム、炭酸水素ナ
トリウム等のアルカリ金属炭酸水素化合物;炭酸カリウ
ム、炭酸ナトリウム等のアルカリ金属炭酸化合物;水酸
化ナトリウム、水酸化カリウム等の水酸化アルカリ金属
化合物;トリエチルアミン等の第三有機級アミン等を反
応系内に共存させることにより空気酸化が実施される。
また、三塩化鉄等の触媒の添加量は、所望の酸化反応が
効率よく終了するのに十分な量でよく、一般にごくわず
かな触媒量であれば良い。かかる触媒のなかでも三塩化
鉄が特に好ましい。反応温度は特に限定されず、0℃〜
100℃、好ましくは室温下にて数時間空気酸化を行な
うことにより式(II)の化合物は純度良く、ほぼ定量
的に目的とする式(I)で示されるジスルフィド化合物
へ変換される。
The present invention will be described below by describing each step in the above reaction formula (c). Step [1] : In this step, 3-mercapto-1- (1,3-thiazolin-2-yl) azetidine represented by the formula (II) is subjected to an oxidation reaction to obtain a compound represented by the formula ( This is a step of deriving a disulfide compound represented by I). The reaction is carried out by using a compound of the formula (II) in an appropriate solvent using an oxidizing agent such as chromic acid, lead tetraacetate, organic peracid, H 2 O 2 , I 2 , dimethylsulfoxide, or the like. This is achieved by performing air oxidation by passing air through the reaction solution in the presence of a catalyst. The solvent used may be any solvent that does not affect the oxidation reaction, that is, a solvent that is inert to the reaction, for example, alcoholic solvents such as methanol, ethanol, propanol, and n-butanol; diethyl ether, tetrahydrofuran, and the like. Ether solvents; hydrocarbon solvents such as n-heptane, n-hexane, cyclohexane, pentane and cyclopentane; ester solvents such as methyl acetate, ethyl acetate; halogen solvents such as dichloromethane, chloroform and carbon tetrachloride Solvent; acetonitrile,
Solvents such as dimethylformamide, dimethylacetamide and dimethylsulfoxide can be used, and among them, alcohol solvents are preferable, and methanol and ethanol are particularly preferable. In this case, as the compound of the formula (II), an acid addition salt thereof can also be used. In such a case, for example, an alkali metal hydrogencarbonate such as potassium hydrogencarbonate or sodium hydrogencarbonate; potassium carbonate An air oxidation is carried out by coexisting an alkali metal carbonate compound such as sodium carbonate, sodium carbonate or the like; an alkali metal hydroxide compound such as sodium hydroxide or potassium hydroxide; a tertiary organic amine such as triethylamine in the reaction system.
The amount of the catalyst such as iron trichloride to be added may be sufficient to end the desired oxidation reaction efficiently, and generally only needs to be a very small amount. Of these catalysts, iron trichloride is particularly preferred. The reaction temperature is not particularly limited.
By subjecting the compound of the formula (II) to air oxidation at 100 ° C., preferably at room temperature for several hours, the compound of the formula (II) is converted to the desired disulfide compound of the formula (I) with high purity and almost quantitatively.

【0035】工程[2]:本工程は、工程[1]におい
て酸化反応に付す式(II)で示される3−メルカプト
−1−(1,3−チアゾリン−2−イル)アゼチジンを
得る工程であり、具体的には、式(III)の3−メル
カプトアゼチジンと、式(IV)で示される2−置換−
1,3−チアゾリン誘導体とを反応させる工程である。
本工程は、式(III)の3−メルカプトアゼチジンと
式(IV)で示される2−置換−1,3−チアゾリン誘
導体とを、前記したなかから適宜選択される反応に不活
性な溶媒、好ましくはメタノール、エタノール等のアル
コール系溶媒中で、適当な塩基、例えば、炭酸水素カリ
ウム、炭酸水素ナトリウム等のアルカリ金属炭酸水素化
合物、炭酸カリウム、炭酸ナトリウム等のアルカリ金属
炭酸化合物、ナトリウムメトキシド、ナトリウムエトキ
シド、カリウム−tert−ブトキシド等のアルカリ金属ア
ルコキシド等の塩基の存在、あるいは不存在下に反応さ
せることにより実施される。
Step [2] : This step is a step of obtaining 3-mercapto-1- (1,3-thiazolin-2-yl) azetidine represented by the formula (II) and subjected to the oxidation reaction in step [1]. And specifically, a 3-mercaptoazetidine of the formula (III) and a 2-substituted-of the formula (IV)
This is a step of reacting with a 1,3-thiazoline derivative.
In this step, a 3-mercaptoazetidine of the formula (III) and a 2-substituted-1,3-thiazoline derivative of the formula (IV) are reacted with a solvent inert to a reaction appropriately selected from the above, Preferably, in an alcoholic solvent such as methanol and ethanol, a suitable base, for example, potassium bicarbonate, alkali metal bicarbonate such as sodium bicarbonate, potassium carbonate, alkali metal carbonate such as sodium carbonate, sodium methoxide, The reaction is carried out in the presence or absence of a base such as an alkali metal alkoxide such as sodium ethoxide and potassium tert-butoxide.

【0036】反応温度は厳密に制限されるものではな
く、使用する溶媒、式(IV)の化合物における脱離基
Lの種類、さらにはその使用量により適宜変更できる
が、一般には室温〜約100℃、好ましくは室温〜約8
0℃の範囲内の温度で行なうことができ、かかる条件下
で反応は約1〜約24時間で終了させることができる。
なお、本工程により得られる式(II)で示される3−
メルカプト−1−(1,3−チアゾリン−2−イル)ア
ゼチジンは、そのまま前記した反応式(a)における式
(B)の化合物と反応させ、抗菌活性を有するカルバペ
ネム化合物へ誘導できる化合物でもあるが、本工程
[2]により得られる式(II)の化合物は、純度的に
満足いくものではなく、夾雑物が混在し、その分離も困
難である。したがって、その点を鑑み、本発明は式(I
I)の化合物を酸化して式(I)の化合物へいったん誘
導したのち、更に還元することにより純度良く、かつほ
ぼ定量的に式(II)の化合物へ戻すことを目的とする
ものであり、別の観点から見れば、本発明は式(II)
の化合物の工業的な精製方法ととらえることも可能であ
る。
The reaction temperature is not strictly limited, and can be appropriately changed depending on the solvent to be used, the type of the leaving group L in the compound of the formula (IV), and the amount of the leaving group. ° C, preferably from room temperature to about 8
The reaction can be carried out at a temperature in the range of 0 ° C., and under such conditions the reaction can be completed in about 1 to about 24 hours.
In addition, 3-
Mercapto-1- (1,3-thiazolin-2-yl) azetidine is a compound which can be directly reacted with the compound of the formula (B) in the above-mentioned reaction formula (a) to induce a carbapenem compound having antibacterial activity. The compound of the formula (II) obtained by this step [2] is not satisfactory in purity, and contains impurities and is difficult to separate. Accordingly, in view of this, the present invention provides a method of formula (I)
A method of oxidizing the compound of formula (I) to induce the compound of formula (I), and then reducing the compound of formula (I) to return the compound of formula (II) with good purity and almost quantitatively; In another aspect, the present invention provides a compound of formula (II)
Can be regarded as an industrial purification method for the compound of the formula (1).

【0037】工程 [3] :本工程は、本発明の式(I)
で示されるジスルフィド化合物の別の製造方法にかかる
工程であり、式(V)で示される化合物に、上記工程
[2]でも使用する式(IV)で示される2−置換−
1,3−チアゾリン誘導体とを反応させて、目的とする
式(I)の化合物を得る工程である。かかる工程では、
上記した工程[2]の反応条件等がそのまま適用され
る。
Step [3] : This step is performed according to the formula (I) of the present invention.
Wherein the compound represented by the formula (V) is replaced with a 2-substituted compound represented by the formula (IV) also used in the step [2].
In this step, the desired compound of formula (I) is obtained by reacting the compound with a 1,3-thiazoline derivative. In such a process,
The reaction conditions and the like in the above step [2] are applied as they are.

【0038】工程[4]および[5]:本工程[4]お
よび工程[5]は、上記工程[3]で使用する式(V)
で示される化合物を得るために、式(VII)で示され
る3−メルカプト−1−アミノ保護基置換−アゼチジン
を酸化し、式(VI)で示されるジスルフィド化合物と
した後、式(VI)のアミノ保護基を脱離して得る工程
である。この場合、式(VII)で示される3−メルカ
プト−1−アミノ保護基置換−アゼチジンを酸化し、式
(VI)で示されるジスルフィド化合物とする工程
[5]は、上記した工程[1]における酸化反応の条件
をそのまま適宜変更して適用することができる。しかし
て、かかる工程に用いる式(VII)で示される3−メ
ルカプト−1−アミノ保護基置換−アゼチジンとして
は、先に例示した各種のアミノ保護基が置換された化合
物であり、この中でもアミノ保護基としてはアセチル等
の脂肪族アシル残基であるものが特に好ましい。本発明
は、この工程により得られた式(VI)の化合物をも提
供するものであり、したがって本発明が目的とするこれ
ら化合物は、R2 として先に例示したアミノ保護基が導
入された化合物を包含することはいうまでもない。さら
に工程[4]における脱アミノ保護基反応を行なうにあ
たっては、ペプチド化学で汎用されている脱アミノ保護
基反応が適用される。例えば先に例示した反応に不活性
な適当な溶媒中、例えば酸による分解等が好ましい。
Steps [4] and [5] : This step [4] and step [5] are performed according to the formula (V) used in step [3].
In order to obtain the compound represented by the formula (VII), 3-mercapto-1-amino protecting group-substituted azetidine represented by the formula (VII) is oxidized to obtain a disulfide compound represented by the formula (VI), This is a step obtained by removing an amino protecting group. In this case, the step [5] of oxidizing the 3-mercapto-1-amino protecting group-substituted azetidine represented by the formula (VII) to obtain a disulfide compound represented by the formula (VI) is performed in the above step [1]. The conditions of the oxidation reaction can be changed as appropriate and applied. The 3-mercapto-1-amino-protecting group-substituted azetidine represented by the formula (VII) used in this step is a compound in which the various amino-protecting groups exemplified above are substituted. As the group, those which are aliphatic acyl residues such as acetyl are particularly preferred. The present invention also provides a compound of the formula (VI) obtained by this step. Therefore, these compounds which are the object of the present invention are compounds having an amino protecting group exemplified above as R 2 . It goes without saying that Further, in performing the deamination protecting group reaction in step [4], a deamination protecting group reaction widely used in peptide chemistry is applied. For example, decomposition in an appropriate solvent inert to the reaction exemplified above, for example, with an acid is preferable.

【0039】かくして製造される式(I)で示されるジ
スルフィド化合物は、例えばトリフェニルホスフィンを
用い、先に例示した反応に不活性な適当な溶媒、例えば
テトラヒドロフラン、アセトニトリル、メタノール、エ
タノール等の溶媒中、例えば1N−塩酸水溶液を用いた
酸性条件下にて処理する還元反応により、純度良くかつ
またほぼ定量的に式(II)で示される3−メルカプト
−1−(1,3−チアゾリン−2−イル)アゼチジンに
変換することができる。このようにして純度良く得られ
た式(II)の化合物は、先に示した反応式(a)にお
ける式(B)の化合物と反応させ、次いで脱保護反応を
行なうことにより、式(A)で示される抗菌活性を有す
るカルバペネム化合物へ誘導される。なお、本発明の工
程[2]により、式(II)の化合物を得ることができ
るが、かかる工程で得た式(II)の化合物は、夾雑物
が混在し、純度的に満足行くものでなく、その精製も困
難である。したがって、本発明は工程[2]で得られた
式(II)の化合物を一旦酸化して式(I)の化合物へ
誘導したのち、更に還元することから、一見無駄な処理
を加えているように思えるが、全工程の収率からみれば
それほど遜色はなく、むしろ式(II)の化合物と式
(B)の化合物との反応収率が格段に向上する点から判
断して、工業的にはよりすぐれた方法となる。特に、式
(B)で示される化合物が高価なものである点を考える
と、純度の良い化合物を使用する点での工業的メリット
は極めて大きなものといえる。
The disulfide compound of the formula (I) thus produced can be prepared, for example, by using triphenylphosphine in a suitable solvent inert to the reaction exemplified above, for example, a solvent such as tetrahydrofuran, acetonitrile, methanol, ethanol or the like. For example, a 3-mercapto-1- (1,3-thiazoline-2-) represented by the formula (II) can be obtained with good purity and almost quantitatively by a reduction reaction treated under acidic conditions using an aqueous 1N hydrochloric acid solution. Il) can be converted to azetidine. The compound of the formula (II) thus obtained with high purity is reacted with the compound of the formula (B) in the above-mentioned reaction formula (a), followed by deprotection to give the compound of the formula (A) To a carbapenem compound having the antibacterial activity shown by Although the compound of the formula (II) can be obtained by the step [2] of the present invention, the compound of the formula (II) obtained in such a step contains impurities and is satisfactory in purity. And its purification is also difficult. Therefore, in the present invention, the compound of the formula (II) obtained in the step [2] is once oxidized to be derived into the compound of the formula (I) and then further reduced, so that seemingly useless treatment is added. However, it is not inferior from the viewpoint of the yields of all the steps, but rather from the viewpoint that the reaction yield of the compound of the formula (II) and the compound of the formula (B) is remarkably improved. Is a better way. In particular, in view of the fact that the compound represented by the formula (B) is expensive, it can be said that the industrial merit of using a compound having high purity is extremely large.

【0040】[0040]

【実施例】以下に実施例および参考例により本発明を更
に詳細に説明するが、これらの記載によってなんらの限
定がなされるものではない。なお、( )内の数字は化
合物番号を示す。実施例1
The present invention will be described in more detail with reference to the following Examples and Reference Examples, which should not be construed as limiting the scope of the present invention. The numbers in parentheses indicate compound numbers. Example 1 :

【0041】[0041]

【化22】 Embedded image

【0042】3−メルカプト−1−(1,3−チアゾリ
ン−2−イル)アゼチジン・塩酸塩(8.60mmo
l)(1)1.81gのメタノール20ml溶液中に、
炭酸水素カリウム2.0gを加え、空気を通気した後、
触媒量の三塩化鉄を加え、室温にて1時間撹拌を行なっ
た。反応終了後、反応液を濾過し、濾液を水200ml
中に滴下し、生成する結晶を濾取した。得られた結晶を
水にて洗浄し、室温にて減圧乾燥し、目的とするジスル
フィド化合物(2)を純度換算収率で定量的に得た。1 H−NMR(270MHz)δ:3.38(t,4
H,J=7.6Hz),3.83〜4.01(m,6
H),4.03(t,4H,J=7.6Hz),4.3
5(t,4H,J=8.1Hz) この化合物を下記の条件によるHPLCで純度測定をし
た結果、その純度はほぼ定量的なものであった。 HPLC測定条件: カラム:Ultron VX−octyl(4.6×2
50mm) 移動層:0.01Mドデシル硫酸ナトリウム−アセトニ
トリル水溶液1:1v/v(リン酸にてpHを2.2に
調整) 流速:1.4ml/分 測定波長:216nm リテンション時間:4.1分 注入量:20μl実施例2
3-mercapto-1- (1,3-thiazolin-2-yl) azetidine hydrochloride (8.60 mmol
l) (1) In a solution of 1.81 g of methanol in 20 ml,
After adding 2.0 g of potassium hydrogen carbonate and ventilating air,
A catalytic amount of iron trichloride was added, and the mixture was stirred at room temperature for 1 hour. After completion of the reaction, the reaction solution was filtered, and the filtrate was washed with 200 ml of water.
The resulting crystals were collected by filtration. The obtained crystals were washed with water and dried under reduced pressure at room temperature to quantitatively obtain the target disulfide compound (2) in a purity-converted yield. 1 H-NMR (270 MHz) δ: 3.38 (t, 4
H, J = 7.6 Hz), 3.83 to 4.01 (m, 6
H), 4.03 (t, 4H, J = 7.6 Hz), 4.3
5 (t, 4H, J = 8.1 Hz) The purity of this compound was measured by HPLC under the following conditions, and as a result, the purity was almost quantitative. HPLC measurement conditions: Column: Ultran VX-octyl (4.6 × 2
50 mm) Moving layer: 0.01 M sodium dodecyl sulfate-acetonitrile aqueous solution 1: 1 v / v (pH adjusted to 2.2 with phosphoric acid) Flow rate: 1.4 ml / min Measurement wavelength: 216 nm Retention time: 4.1 minutes Injection volume: 20 μl Example 2 :

【0043】[0043]

【化23】 Embedded image

【0044】3−メルカプトアゼチジン・塩酸塩(3)
2.39g(19.04mmol)のメタノール40m
l溶液中に、2−メチルチオ−1,3−チアゾリン
(4)2.41mlを加え、4時間還流した。反応終了
後、生成した3−メルカプト−1−(1,3−チアゾリ
ン−2−イル)アゼチジン・塩酸塩(1)を反応液から
単離することなく、そのままの反応液を用い、これに炭
酸水素カリウム3.6gを加え、空気を通気した後、触
媒量の三塩化鉄を加え、室温にて1時間撹拌を行なっ
た。反応終了後、反応液を濾過し、濾液を水300ml
中に滴下し、生成する結晶を濾取した。得られた結晶を
水にて洗浄し、室温にて減圧乾燥し、目的とするジスル
フィド化合物(2)を純度換算収率で定量的に得た。こ
のもののNMRデータは実施例1で得られたものと同一
であった。また、同様HPLCによる純度測定を行なっ
たが、ほぼ定量的含有量であった。実施例3
3-mercaptoazetidine hydrochloride (3)
2.39 g (19.04 mmol) of methanol 40m
To this solution, 2.41 ml of 2-methylthio-1,3-thiazoline (4) was added, and the mixture was refluxed for 4 hours. After completion of the reaction, the produced 3-mercapto-1- (1,3-thiazolin-2-yl) azetidine / hydrochloride (1) was used as it was without isolating it from the reaction solution. After adding 3.6 g of potassium hydrogen and passing air, a catalytic amount of iron trichloride was added, and the mixture was stirred at room temperature for 1 hour. After completion of the reaction, the reaction solution was filtered, and the filtrate was 300 ml of water.
The resulting crystals were collected by filtration. The obtained crystals were washed with water, and dried under reduced pressure at room temperature to quantitatively obtain the target disulfide compound (2) in a yield in terms of purity. Its NMR data was identical to that obtained in Example 1. The purity was measured by HPLC in the same manner, and the content was almost quantitative. Example 3 :

【0045】[0045]

【化24】 Embedded image

【0046】化合物(5)1.86g(10.75mm
ol)のメタノール27ml溶液にナトリウムメトキシ
ド2.19gを加え、室温にて30分撹拌した。次いで
6N−塩酸水溶液2.15mlを加え、15分間撹拌し
た。かくして化合物(6)を得、このものを単離するこ
となくこの反応液に炭酸水素カリウム2.15gを加
え、空気を通気しながら、触媒量の三塩化鉄を加え、室
温にて2時間撹拌を行なった。反応終了後、反応液を濾
過し、濾液を濃縮し、化合物(7)を得た。1 H−NMR(270MHz)δ:1.88(s、6
H),3.79〜3.99(m,4H),4.01〜
4.15(m,2H),4.25〜4.36(m,2
H),4.40〜4.50(m,2H) 得られた化合物(7)に3N−塩酸水溶液4.3mlを
加え、1時間加熱還流した。室温に放冷後、塩酸層を酢
酸エチル3.61mlおよび水3.61mlを加えて洗
浄し、水層を減圧濃縮した後、残留物を室温にて18時
間減圧乾燥すると、固形物として化合物(8)を1.2
g得た。次いでこの化合物(8)をメタノール27ml
に溶解し、この溶液に3−メルカプトアゼチジン1.2
1mlを加え、4時間還流した。反応終了後、メタノー
ルを減圧留去し、得られた残留物に酢酸エチル13.5
mlおよび水54mlを加え、水層を分離した。水層に
メタノール10mlを加え、室温にて撹拌し、さらに1
0N−水酸化ナトリウム水溶液1.3mlを加え撹拌を
行なうと結晶が析出した。得られた結晶を濾取し、水に
て洗浄後、室温にて18時間減圧乾燥し、木手とするジ
スルフィド化合物(2)を1.18g得た。このものの
NMRデータは実施例1のものと同一であり、その純度
は、同様HPLC法により行ない、ほぼ定量的な純度で
あった。参考例1
1.86 g (10.75 mm) of compound (5)
ol) in 27 ml of methanol was added with 2.19 g of sodium methoxide, and the mixture was stirred at room temperature for 30 minutes. Then, 2.15 ml of 6N-hydrochloric acid aqueous solution was added, and the mixture was stirred for 15 minutes. Thus, compound (6) was obtained, and without isolation, 2.15 g of potassium hydrogen carbonate was added to the reaction solution, and a catalytic amount of iron trichloride was added thereto while passing air through, followed by stirring at room temperature for 2 hours. Was performed. After completion of the reaction, the reaction solution was filtered, and the filtrate was concentrated to obtain a compound (7). 1 H-NMR (270 MHz) δ: 1.88 (s, 6
H), 3.79 to 3.99 (m, 4H), 4.01 to
4.15 (m, 2H), 4.25 to 4.36 (m, 2
H), 4.40 to 4.50 (m, 2H) To the obtained compound (7), 4.3 ml of a 3N aqueous hydrochloric acid solution was added, and the mixture was heated under reflux for 1 hour. After cooling to room temperature, the hydrochloric acid layer was washed by adding 3.61 ml of ethyl acetate and 3.61 ml of water, and the aqueous layer was concentrated under reduced pressure. The residue was dried at room temperature for 18 hours under reduced pressure to give the compound (as a solid). 8) to 1.2
g was obtained. Next, this compound (8) was added to 27 ml of methanol.
And 3-mercaptoazetidine 1.2 was added to this solution.
1 ml was added and the mixture was refluxed for 4 hours. After completion of the reaction, methanol was distilled off under reduced pressure, and the obtained residue was ethyl acetate (13.5).
ml and 54 ml of water were added and the aqueous layer was separated. 10 ml of methanol was added to the aqueous layer, and the mixture was stirred at room temperature.
When 1.3 ml of 0N-sodium hydroxide aqueous solution was added and stirred, crystals were precipitated. The obtained crystals were collected by filtration, washed with water, and dried under reduced pressure at room temperature for 18 hours to obtain 1.18 g of a disulfide compound (2) which was used as a metal. The NMR data of this product was the same as that of Example 1, and the purity was almost quantitative by a HPLC method. Reference Example 1 :

【0047】[0047]

【化25】 Embedded image

【0048】3−メルカプトアゼチジン・塩酸塩(3)
720mgのメタノール10ml溶液に2−メチルチオ
−1,3−チアゾリン(4)0.67mlを加え、3時
間還流した。反応終了後、反応液を減圧濃縮し、得られ
た残渣に水15mlを加え、酢酸エチル10mlで2回
洗浄し、水層を減圧濃縮した。得られた残渣にアセトニ
トリル1mlを加え撹拌し、テトラヒドロフラン6ml
を20分を要して滴下し、結晶を析出させた。得られた
結晶を濾取し、室温にて18時間減圧乾燥し、目的とす
る3−メルカプト−1−(1,3−チアゾリン−2−イ
ル)アゼチジン・塩酸塩(1)を1.05g得た。この
ものの純度換算収率は84.8%であり、純度は86.
7%であった。参考例2
3-mercaptoazetidine hydrochloride (3)
To a solution of 720 mg in 10 ml of methanol was added 0.67 ml of 2-methylthio-1,3-thiazoline (4), and the mixture was refluxed for 3 hours. After completion of the reaction, the reaction solution was concentrated under reduced pressure, 15 ml of water was added to the obtained residue, and the mixture was washed twice with 10 ml of ethyl acetate, and the aqueous layer was concentrated under reduced pressure. 1 ml of acetonitrile was added to the obtained residue and stirred, and 6 ml of tetrahydrofuran was stirred.
Was added dropwise over 20 minutes to precipitate crystals. The obtained crystals were collected by filtration and dried under reduced pressure at room temperature for 18 hours to obtain 1.05 g of the objective 3-mercapto-1- (1,3-thiazolin-2-yl) azetidine hydrochloride (1). Was. Its yield in terms of purity was 84.8%, and its purity was 86.0%.
7%. Reference Example 2 :

【0049】[0049]

【化26】 Embedded image

【0050】方法(a):実施例1で得たジスルフィド
化合物(2)2.62gのテトラヒドロフラン溶液に1
N−塩酸水溶液を加え、そこにトリフェニルホスフィン
1.89gを加え、50〜60℃にて2時間撹拌した。
反応終了後、酢酸エチル10mlおよび水10mlを加
え、水層を分取し、減圧濃縮した。得られた残渣にメタ
ノール1.2mlを加え撹拌し、そこへ酢酸エチル24
mlを15分を要して滴下し、結晶を析出させた。得ら
れた結晶を濾取し、室温にて18時間減圧乾燥し、目的
とする3−メルカプト−1−(1,3−チアゾリン−2
−イル)アゼチジン・塩酸塩(1)を2.62g得た。
このものの純度換算収率は94%であり、純度は96.
7%であった。 方法(b):実施例1で得たジスルフィド化合物(2)
693.1mgのアセトニトリル4ml溶液に水0.0
43mlおよび14.6N−塩酸のメタノール溶液0.
34mlを加え、さらにトリフェニルホスフィン62
9.5mgを加え、室温にて1.5時間撹拌した。反応
終了後、テトラヒドロフラン40mlを滴下し、室温に
て3時間撹拌し、結晶を析出させた。得られた結晶を濾
取し、室温にて18時間減圧乾燥し、目的とする3−メ
ルカプト−1−(1,3−チアゾリン−2−イル)アゼ
チジン・塩酸塩(1)を837mg得た。このものの純
度換算収率は96.8%であり、純度は97.5%であ
った。
Method (a): A solution of 2.62 g of the disulfide compound (2) obtained in Example 1 in tetrahydrofuran was added.
An N-hydrochloric acid aqueous solution was added, and 1.89 g of triphenylphosphine was added thereto, followed by stirring at 50 to 60 ° C for 2 hours.
After completion of the reaction, 10 ml of ethyl acetate and 10 ml of water were added, and the aqueous layer was separated and concentrated under reduced pressure. 1.2 ml of methanol was added to the obtained residue, and the mixture was stirred.
ml was added dropwise over 15 minutes to precipitate crystals. The obtained crystals were collected by filtration and dried under reduced pressure at room temperature for 18 hours to give the desired 3-mercapto-1- (1,3-thiazoline-2).
2.62 g of -yl) azetidine hydrochloride (1) were obtained.
Its purity conversion yield was 94%, and its purity was 96.
7%. Method (b): disulfide compound (2) obtained in Example 1
To a solution of 693.1 mg of acetonitrile in 4 ml of water 0.0
43 ml and a solution of 14.6N hydrochloric acid in methanol 0.
34 ml of triphenylphosphine 62
9.5 mg was added, and the mixture was stirred at room temperature for 1.5 hours. After completion of the reaction, 40 ml of tetrahydrofuran was added dropwise, and the mixture was stirred at room temperature for 3 hours to precipitate crystals. The obtained crystals were collected by filtration and dried under reduced pressure at room temperature for 18 hours to obtain 837 mg of the desired 3-mercapto-1- (1,3-thiazolin-2-yl) azetidine hydrochloride (1). Its yield in terms of purity was 96.8%, and its purity was 97.5%.

───────────────────────────────────────────────────── フロントページの続き (58)調査した分野(Int.Cl.7,DB名) C07D 417/14 C07D 205/04 CA(STN) REGISTRY(STN)──────────────────────────────────────────────────続 き Continued on the front page (58) Field surveyed (Int. Cl. 7 , DB name) C07D 417/14 C07D 205/04 CA (STN) REGISTRY (STN)

Claims (5)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】 次式(I): 【化1】 で示されるジスルフィド化合物およびその酸付加塩。(1) The following formula (I): And the acid addition salt thereof. 【請求項2】 次式(II): 【化2】 で示される3−メルカプト−1−(1,3−チアゾリン
−2−イル)アゼチジンまたはその酸付加塩を酸化反応
に付すことを特徴とする、請求項1記載の式(I)で示
されるジスルフィド化合物またはその酸付加塩の製造
法。
2. The following formula (II): 3. A disulfide represented by the formula (I) according to claim 1, wherein the 3-mercapto-1- (1,3-thiazolin-2-yl) azetidine or an acid addition salt thereof is subjected to an oxidation reaction. A method for producing a compound or an acid addition salt thereof.
【請求項3】 次式(III): 【化3】 で示される3−メルカプトアゼチジンに、次式(I
V): 【化4】 (式中、Lは脱離基を表す)で示される2−置換−1,
3−チアゾリン誘導体を反応させて次式(II): 【化5】 で示される3−メルカプト−1−(1,3−チアゾリン
−2−イル)アゼチジンを得、次いで得られる式(I
I)の化合物を反応液から単離することなくそのまま酸
化反応に付すことを特徴とする、請求項1記載の式
(I)で示されるジスルフィド化合物またはその酸付加
塩の製造法。
3. The following formula (III): The 3-mercaptoazetidine represented by the following formula (I)
V): embedded image (Wherein L represents a leaving group)
Reaction of the 3-thiazoline derivative with the following formula (II): 3-mercapto-1- (1,3-thiazolin-2-yl) azetidine represented by the following formula:
The method for producing a disulfide compound represented by the formula (I) or an acid addition salt thereof according to claim 1, wherein the compound of the formula (I) is subjected to an oxidation reaction without isolation from the reaction solution.
【請求項4】 次式(V): 【化6】 で示される化合物に、次式(IV): 【化7】 (式中、Lは脱離基を表す)で示される2−置換−1,
3−チアゾリン誘導体を反応させることを特徴とする、
請求項1記載の式(I)で示されるジスルフィド化合物
またはその酸付加塩の製造法。
4. The following formula (V): Has the following formula (IV): (Wherein L represents a leaving group)
Characterized by reacting a 3-thiazoline derivative,
A method for producing a disulfide compound represented by the formula (I) according to claim 1 or an acid addition salt thereof.
【請求項5】 次式(VI): 【化8】 (式中、R1 は水素原子またはアミノ保護基を表す)で
示される化合物。
5. The following formula (VI): (Wherein, R 1 represents a hydrogen atom or an amino-protecting group).
JP10860296A 1996-04-05 1996-04-05 Disulfide compound and method for producing the same Expired - Lifetime JP3209679B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP10860296A JP3209679B2 (en) 1996-04-05 1996-04-05 Disulfide compound and method for producing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10860296A JP3209679B2 (en) 1996-04-05 1996-04-05 Disulfide compound and method for producing the same

Publications (2)

Publication Number Publication Date
JPH09278776A JPH09278776A (en) 1997-10-28
JP3209679B2 true JP3209679B2 (en) 2001-09-17

Family

ID=14488968

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10860296A Expired - Lifetime JP3209679B2 (en) 1996-04-05 1996-04-05 Disulfide compound and method for producing the same

Country Status (1)

Country Link
JP (1) JP3209679B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2016288230A1 (en) 2015-07-02 2018-01-25 Horizon Orphan Llc ADO-resistant cysteamine analogs and uses thereof

Also Published As

Publication number Publication date
JPH09278776A (en) 1997-10-28

Similar Documents

Publication Publication Date Title
JP3948628B2 (en) Method for producing cefdinir
US5091525A (en) Monohydrate and DMF solvates of a new carbacephem antibiotic
FI75163B (en) FOERFARANDE FOER FRAMSTAELLNING AV NYA PENEMKARBOXYLSYROR ELLER -ESTRAR.
WO1998012197A1 (en) Intermediates for the preparation of duocarmycin sa and derivatives thereof, and process for the production of the intermediates
KR101202209B1 (en) Process for producing muscarine receptor antagonist and intermediate therefor
US20080009634A1 (en) Process for synthesizing beta-lactamase inhibitor intermediates
JPS60214792A (en) Penamylacid ester derivative
JP3209679B2 (en) Disulfide compound and method for producing the same
US6011159A (en) Processes and intermediates for preparing substituted indazole derivatives
HU223472B1 (en) Novel thiazoline intermediates
JP4294121B2 (en) Process for producing pyridonecarboxylic acid derivatives and intermediates thereof
Rodrı́guez et al. An improved method for preparation of cefpodoxime proxetil
JPH07179445A (en) Intermediate useful for manufacturing sephem prodrug ester
JPH07173153A (en) 1-(2-amino-5-(1-(triphenylmethyl)-1h-imidazol-4-yl)-1- oxopentyl)piperidine derivative, its preparation and its useas synthesis intermediate
US20060009639A1 (en) Process for the preparation of cefpodoxime proxetil
JP2004099494A (en) Method for producing optically active tricyclic compound
JP3219833B2 (en) Method for producing 4-substituted propylazetidin-2-one derivative
EP0186586A2 (en) Cephem compounds and the production thereof
JP3684339B2 (en) Method for producing carbapenem compounds
JPH05221947A (en) Production of cyclopropane derivative
JP3209675B2 (en) Thiol compounds
Ha et al. A convergent scheme for the stereoselective synthesis of 3'-nor-1-oxacephems
JP2733256B2 (en) 4-mercaptopyrazolidine derivative
JP2000169445A (en) Production of optically active 4-mercapto-2-pyrrolidinone derivative
JP2898029B2 (en) Cephem derivative dimethylformamide solvated crystal

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080713

Year of fee payment: 7

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080713

Year of fee payment: 7

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090713

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090713

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100713

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100713

Year of fee payment: 9

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313111

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110713

Year of fee payment: 10

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110713

Year of fee payment: 10

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120713

Year of fee payment: 11

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130713

Year of fee payment: 12

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term